Divalproex Sodium Tablet, Delayed Release
Product Images NDC 68001-474

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 68001-474). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (39cef9df 868d 4963 B0a7 7f146275442f 01)

FDA Label Image

Image (39cef9df 868d 4963 B0a7 7f146275442f 02)

FDA Label Image

Image (39cef9df 868d 4963 B0a7 7f146275442f 03)

FDA Label Image

Image (39cef9df 868d 4963 B0a7 7f146275442f 04)

FDA Label Image

Image (39cef9df 868d 4963 B0a7 7f146275442f 05)

FDA Label Image

Divalproex 125mg (39cef9df 868d 4963 B0a7 7f146275442f 07)

This is a pharmaceutical product containing Divalproex Sodium, USP equivalent to Valproic acid 25mg. It is a delayed-release enteric-coated tablet that is stored at a temperature range of 20° to 25°C. The tablets are dispensed in a tight, light-resistant container, and a seal over the bottle opening should not be broken or missing. The medication guide contained should be given to each patient by the pharmacist. This product is produced by UNICHEM laboratories in India and distributed by BluePoint Laboratories.*

FDA Label Image

Divalproex 250mg (39cef9df 868d 4963 B0a7 7f146275442f 08)

This is a description of Divalproex Sodium Delayed Release Tablets, USP. Each tablet contains 250 mg of Divalproex sodium, which is equivalent to Valproic acid. It is recommended to store the tablets at controlled room temperature, and to dispense them in a tight, light-resistant container. The text includes a caution against accepting the tablets if the seal over the bottle opening is broken or missing. The tablets come with a medication guide to be dispensed to each patient. They are manufactured by Unichem Laboratories Ltd. in India and distributed by BluePoint Laboratories.*

FDA Label Image

Divalproex 500mg (39cef9df 868d 4963 B0a7 7f146275442f 09)

This is a description of Divalproex Sodium Delayed Release Tablets, USP. Each enteric-coated tablet contains 500mg of Divalproex Sodium, which is equivalent to Valproic Acid. The tablets should be stored at a temperature of 20° to 25°C (68°to 77°F) and dispensed in a tight, light-resistant container as defined in the USP. The prescribing information is enclosed. Patients should not accept the medication if the seal over the bottle opening is broken or missing. The tablets are to be dispensed with a medication guide enclosed to each patient by a pharmacist. The manufacturer is Unichem Laboratories Ltd. and the tablets are packaged for BluePoint Laboratories.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.